Medulloblastoma Subtyping Assay (SJ-10-0020)
Technology Name
(St. Jude Reference #) |
Medulloblastoma Subtyping Assay (SJ-10-0020) |
| Description |
A series of immunohistochemical tests are provided that allow medulloblastoma (and perhaps other) tumor samples to be classified into three main subgroups: those driven by the Sonic Hedgehog pathway, those driven by the Wnt pathway, and all others. This subtyping is critical for determining appropriate therapeutic treatment strategies. |
| Keywords |
Medulloblastoma, Sonic Hedgehog, Subtyping |
| Granted Patents or Published Applications |
International application published April 5, 2012 as WO 2012/044921 |
| Related Scientific References |
Ma et al., “Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia”, Nature Genetics 28(3): 220-221 (2001)
Ellison,,D. W. et al., “Medulloblastoma: clinicopathological correlates of SHH, WNT,and non-SHH/WNT molecular subgroups”, Acta Neuropathology 121(3): 381-396 (Jan. 26, 2011).
|
| Licensing Opportunities |
We are currently seeking licensing opportunities in all fields for the development of this technology. |
| |
|
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.
Last update: October 2012